What is Thymosin Alpha-1?
Thymosin Alpha-1 is a 28-amino-acid peptide produced naturally by the thymus gland — the organ responsible for T-cell development and immune programming. As we age, the thymus involutes (shrinks), leading to declining Tα1 production and progressive deterioration of immune function. This is a key mechanism behind age-related immune decline.
Synthetic Thymosin Alpha-1 (brand name Zadaxin) has been approved in over 35 countries for treatment of hepatitis B, hepatitis C, and as a vaccine adjuvant. In the United States, it is used off-label as a research compound. Its clinical record spans more than 30 years of use across dozens of countries, making it one of the best-documented immune-modulating peptides available.
A different category from most peptides: While most peptides on this site target recovery, body composition, or hormonal optimization, Thymosin Alpha-1 primarily targets the immune system. It is especially valuable for people with chronic infections, autoimmune conditions, post-viral fatigue (including long COVID), or age-related immune decline.
Key benefits of Thymosin Alpha-1
Here is what the research and clinical experience suggest Thymosin Alpha-1 can do:
Immune system restoration
Restores T-cell function and increases the activity of natural killer (NK) cells — the front line of immune defense.
Anti-inflammatory
Reduces chronic, low-grade inflammation (“inflammaging”) — a major driver of aging and age-related disease.
Antiviral properties
Shown to enhance clearance of viral infections including hepatitis B, hepatitis C, and respiratory viruses.
Vaccine potentiation
Significantly improves the immune response to vaccines — particularly valuable in immunocompromised patients.
Post-viral recovery
Increasingly used for long COVID and other post-viral fatigue syndromes to restore immune homeostasis.
Longevity support
By maintaining healthy immune surveillance, Tα1 helps reduce cancer risk and support cellular health into old age.
How does Thymosin Alpha-1 work?
T-cell activation and regulation
Thymosin Alpha-1 activates dendritic cells and macrophages, which present antigens to T cells and initiate adaptive immune responses. It upregulates Toll-like receptors (TLRs) that detect pathogens, enhancing the speed and specificity of immune responses to infections.
Th1/Th2 immune balance
Tα1 helps restore balance between Th1 (cellular immunity, fights viruses and intracellular pathogens) and Th2 (humoral immunity, antibody-mediated) responses. Many chronic illnesses involve an imbalance toward Th2 dominance — Tα1 shifts the balance back toward Th1, which is more effective against intracellular infections and cancer cells.
mTOR and anti-inflammatory pathways
Tα1 modulates mTOR signaling — a key pathway in cellular aging and inflammation — and reduces production of pro-inflammatory cytokines including TNF-α and IL-6. This makes it effective not just as an immune stimulant but as a systemic anti-inflammatory agent.
Dosing guide
Dosing varies depending on your goal and method of administration. Always work with a licensed provider to determine your specific protocol.
| Goal | Typical dose | Frequency | Method |
|---|---|---|---|
| Immune support / anti-aging | 1.6 mg | Twice weekly for 4–6 weeks, then maintenance | Subcutaneous injection |
| Chronic infection | 1.6 mg | Twice weekly for 6–12 months | Subcutaneous injection |
| Post-viral recovery | 1.6 mg | Twice weekly for 3–6 months | Subcutaneous injection |
| Vaccine potentiation | 1.6 mg | Day before and day of vaccination | Subcutaneous injection |
Important: Dosing information here is educational only. The right protocol for you depends on your health history, goals, and body weight. A licensed clinic can prescribe and supervise your treatment safely.
Side effects & safety
Thymosin Alpha-1 has an exceptional safety record based on decades of clinical use in dozens of countries. Serious adverse events are extremely rare. It is one of the most well-tolerated peptides in clinical use.
Possible side effects include: Mild injection site reactions (redness, slight swelling), occasional mild flu-like symptoms in the first few days of use (a positive sign of immune activation), and transient fatigue. No organ toxicity, hormonal interference, or serious systemic adverse events have been documented at therapeutic doses.
Because Tα1 modulates rather than broadly stimulates the immune system, it is generally well-tolerated even in patients with autoimmune conditions — though provider oversight is important in those cases.
Related guides: BPC-157 for tissue repair | NAD+ for cellular health | Peptides for anti-aging